Matthew Powell, MD, discusses long-term overall survival results with dostarlimab plus chemo in dMMR endometrial cancer ...
It was a busy year in 2025 for area court systems, with large and complex cases making their way toward trial in 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results